Apart from well-known somatic mutations in KRAS, TP53, SMAD4 and CDKN2A, each of which is altered in >50% of patients, PC is highly heterogeneous with a myriad of driver and passenger alterations in numerous genes. This evidence concerns the gene KRAS and pachyonychia congenita.